期刊文献+

迷走神经刺激对难治性癫痫疗效的预测指标 被引量:2

Predictors of efficacy before vagus nerve stimulation in drug-resistant epilepsy
原文传递
导出
摘要 迷走神经刺激是治疗药物难治性癫痫的有效手段,经过20余年的临床实践经验,其有效性与安全性得到充分验证。但由于作用机制尚未明确,目前仍无可靠预测指标来评估可能从迷走神经刺激术中获益的难治性癫痫患者。研究表明,可能的特异性预测指标包括年龄、癫痫发作类型、癫痫病因、癫痫综合征类型、认知与行为水平、头皮脑电图相关指标及心率变异性相关指标等,但因研究设计等因素的异质性,导致其中部分指标仍有争议。现根据相关文献资料进行分析、整理和归纳,综述迷走神经刺激术对难治性癫痫疗效的预测指标,希望为未来研究提供方向。 Vagus nerve stimulation is an effective treatment for drug-resistant epilepsy,and its efficacy and safety have been confirmed after over two decades of clinical practices.However,reassuring predictors to evaluate whether patients with drug-resistant epilepsy could gain benefit from vagus nerve stimulation has not been established,because the underlying mechanism remain poorly understood.Previous studies revealed that presumable patient-related predictors included age,epileptic seizure type,epilepsy etiology,epilepsy syndrome,cognitive and behavioral responsiveness,scalp electroencephalographic related signals and heart rate variability related signals.However,most of the predictors still remain controversial due to the factors such as the heterogeneity of different research design.This article aims at analyzing and concluding the information from relevant literatures,and summing up the predictors of efficacy before vagus nerve stimulation in refractory epilepsy to highlight the future work.
作者 马嘉翼 吴晔 Ma Jiayi;Wu Ye(Department of Pediatrics,Peking University First Hospital,Beijing 100034,China)
出处 《中华实用儿科临床杂志》 CAS CSCD 北大核心 2021年第7期551-554,共4页 Chinese Journal of Applied Clinical Pediatrics
关键词 药物难治性癫痫 迷走神经刺激 预测指标 Drug-resistant epilepsy Vagus nerve stimulation Predictor
  • 相关文献

参考文献1

二级参考文献21

  • 1KwanP,BrodieMJ.Early identification of refractory epilepsy[J].N Engl J Med,2000,342(5):314–319.DOI:10.1056/NEJM200002033420503.
  • 2MohanrajR,BrodieMJ.Diagnosing refractory epilepsy:response to sequential treatment schedules[J].Eur J Neurol,2006,13(3):277–282.DOI:10.1111/j.1468–1331.2006.01215.x.
  • 3BrodieMJ,BarrySJ,BamagousGA,et al.Patterns of treatment response in newly diagnosed epilepsy[J].Neurology,2012,78(20):1548–1554.DOI:10.1212/WNL.0b013e3182563b19.
  • 4KwanP,ArzimanoglouA,BergAT,et al.Definition of drug resistant epilepsy:consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies[J].Epilepsia,2010,51(6):1069–1077.DOI:10.1111/j.1528–1167.2009.02397.x.
  • 5BrodieMJ,SchachterSC,KwanPKL.Fast facts:epilepsy[M].Albuquerque:Health Press,2012:60–62.
  • 6MctagueA,CrossJH.Treatment of epileptic encephalopathies[J].CNS Drugs,2013,27(3):175–184.DOI:10.1007/s40263–013–0041–6.
  • 7FejermanN.Atypical rolandic epilepsy[J].Epilepsia,2009,50(Suppl 7):S9–12.DOI:10.1111/j.1528–1167.2009.02210.x.
  • 8OguniM,OguniH,ItoS,et al.Re–evaluation of ketogenic diet therapy for childhood refractory epilepsy[J].No To Hattatsu,2009,41(5):339–342.
  • 9SuoC,LiaoJ,LuX,et al.Efficacy and safety of the ketogenic diet in Chinese children[J].Seizure,2013,22(3):174–178.DOI:10.1016/j.seizure.2012.11.014.
  • 10SharmaS,TripathiM.Ketogenic diet in epileptic encephalopathies[J].Epilepsy Res Treat,2013,2013:652052.DOI:10.1155/2013/652052.

共引文献28

同被引文献23

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部